Agilon Health Inc has a consensus price target of $15.78, established from looking at the 66 latest analyst ratings. The last 3 analyst ratings were released from Stifel, Citigroup, and Barclays on May 1, 2024, April 22, 2024, and March 6, 2024. With an average price target of $6 between Stifel, Citigroup, and Barclays, there's an implied 14.94% upside for Agilon Health Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Agilon Health (NYSE: AGL) was reported by Stifel on May 1, 2024. The analyst firm set a price target for $7.00 expecting AGL to rise to within 12 months (a possible 27.27% upside). 29 analyst firms have reported ratings in the last year.
The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Stifel, and Agilon Health maintained their hold rating.
There is no last upgrade for Agilon Health.
The last downgrade for Agilon Health Inc happened on February 26, 2024 when TD Cowen changed their price target from $12 to $6.5 for Agilon Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on May 1, 2024 so you should expect the next rating to be made available sometime around May 1, 2025.
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $8.00 to $7.00. The current price Agilon Health (AGL) is trading at is $5.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.